Breaking News Instant updates and real-time market news.

SBSW

Sibanye Stillwater

$10.05 /

+0.1 (+1.01%)

05:36
07/07/22
07/07
05:36
07/07/22
05:36

Sibanye Stillwater downgraded to Hold from Buy at Investec

Investec analyst Nkateko Mathonsi downgraded Sibanye Stillwater to Hold from Buy with a ZAR 47 price target.

OTHER BREAKING NEWS FROM THE FLY

Earnings
Katapult reports Q2 EPS (10c) vs. (17c) last year » 07:12
08/09/22
08/09
07:12
08/09/22
07:12
KPLT

Katapult

$1.53 /

+0.06 (+4.08%)

Reports Q2 revenue $53M…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KPLT Katapult
$1.53 /

+0.06 (+4.08%)

KPLT Katapult
$1.53 /

+0.06 (+4.08%)

05/11/22 Loop Capital
Katapult downgraded to Hold from Buy at Loop Capital
10/05/21 Cantor Fitzgerald
Katapult initiated with a Neutral at Cantor Fitzgerald
09/03/21 KeyBanc
Katapult well positioned to benefit from new partnerships, says KeyBanc
08/12/21 Loop Capital
Katapult price target lowered to $7 from $12 at Loop Capital
KPLT Katapult
$1.53 /

+0.06 (+4.08%)

KPLT Katapult
$1.53 /

+0.06 (+4.08%)

Upgrade
Restaurant Brands upgraded to Buy from Hold at Argus » 07:12
08/09/22
08/09
07:12
08/09/22
07:12
QSR

Restaurant Brands

$59.26 /

-0.27 (-0.45%)

Argus analyst John…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
QSR Restaurant Brands
$59.26 /

-0.27 (-0.45%)

QSR Restaurant Brands
$59.26 /

-0.27 (-0.45%)

08/05/22 Baird
Restaurant Brands price target raised to $63 from $56 at Baird
08/05/22 Deutsche Bank
Restaurant Brands price target raised to $70 from $64 at Deutsche Bank
07/18/22 Morgan Stanley
Restaurant Brands price target lowered to $52 from $56 at Morgan Stanley
07/11/22 Deutsche Bank
Restaurant Brands price target lowered to $64 from $70 at Deutsche Bank
QSR Restaurant Brands
$59.26 /

-0.27 (-0.45%)

QSR Restaurant Brands
$59.26 /

-0.27 (-0.45%)

Hot Stocks
Axsome Therapeutics announces upcoming milestones » 07:12
08/09/22
08/09
07:12
08/09/22
07:12
AXSM

Axsome Therapeutics

$43.33 /

-0.58 (-1.32%)

Anticipated Milestones:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AXSM Axsome Therapeutics
$43.33 /

-0.58 (-1.32%)

AXSM Axsome Therapeutics
$43.33 /

-0.58 (-1.32%)

07/08/22 Morgan Stanley
Axsome Therapeutics price target raised to $54 from $27 at Morgan Stanley
06/29/22 Cowen
Axsome Therapeutics price target raised to $130 from $120 at Cowen
06/29/22 Cantor Fitzgerald
Axsome Therapeutics price target raised to $64 from $47 at Cantor Fitzgerald
05/06/22 Morgan Stanley
Morgan Stanley says 'outsized pressure' on Axsome may be due to conference news
AXSM Axsome Therapeutics
$43.33 /

-0.58 (-1.32%)

AXSM Axsome Therapeutics
$43.33 /

-0.58 (-1.32%)

AXSM Axsome Therapeutics
$43.33 /

-0.58 (-1.32%)

Downgrade
Charter downgraded to Hold from Buy at Argus » 07:12
08/09/22
08/09
07:12
08/09/22
07:12
CHTR

Charter

$464.36 /

+1.19 (+0.26%)

Argus analyst Joseph…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CHTR Charter
$464.36 /

+1.19 (+0.26%)

CHTR Charter
$464.36 /

+1.19 (+0.26%)

08/01/22 Morgan Stanley
Charter price target lowered to $550 from $600 at Morgan Stanley
08/01/22 Deutsche Bank
Charter price target lowered to $550 from $575 at Deutsche Bank
08/01/22 Barclays
Charter downgraded to Underweight from Equal Weight at Barclays
08/01/22 Pivotal Research
Charter price target lowered to $560 from $585 at Pivotal Research
CHTR Charter
$464.36 /

+1.19 (+0.26%)

CHTR Charter
$464.36 /

+1.19 (+0.26%)

CHTR Charter
$464.36 /

+1.19 (+0.26%)

CHTR Charter
$464.36 /

+1.19 (+0.26%)

Recommendations
Lundin Mining price target lowered to C$8 from C$10.25 at Deutsche Bank » 07:11
08/09/22
08/09
07:11
08/09/22
07:11
LUNMF

Lundin Mining

$5.41 /

+0.11 (+2.08%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LUNMF Lundin Mining
$5.41 /

+0.11 (+2.08%)

LUNMF Lundin Mining
$5.41 /

+0.11 (+2.08%)

07/29/22 UBS
Lundin Mining price target lowered to SEK 60 from SEK 65 at UBS
07/29/22 Deutsche Bank
Lundin Mining price target lowered to SEK 65 from SEK 75 at Deutsche Bank
07/29/22 Canaccord
Lundin Mining price target lowered to C$10.50 from C$11.50 at Canaccord
07/29/22 RBC Capital
Lundin Mining price target lowered to C$10 from C$14 at RBC Capital
LUNMF Lundin Mining
$5.41 /

+0.11 (+2.08%)

Hot Stocks
Achilles Therapeutics expects cash to fund operations into 2Q25 » 07:11
08/09/22
08/09
07:11
08/09/22
07:11
ACHL

Achilles Therapeutics

$3.04 /

+0.09 (+3.05%)

Cash and cash equivalents…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACHL Achilles Therapeutics
$3.04 /

+0.09 (+3.05%)

ACHL Achilles Therapeutics
$3.04 /

+0.09 (+3.05%)

05/27/22 Piper Sandler
Achilles Therapeutics price target lowered to $10 from $17 at Piper Sandler
05/10/22 Piper Sandler
Achilles Therapeutics price target lowered to $17 from $20 at Piper Sandler
03/01/22 Piper Sandler
Achilles Therapeutics price target lowered to $20 from $23 at Piper Sandler
11/12/21 Piper Sandler
Achilles provides clinical update for ATL001 trials, says Piper Sandler
ACHL Achilles Therapeutics
$3.04 /

+0.09 (+3.05%)

Earnings
Novanta raises FY22 adjusted EPS view to $2.96-$3.02 from $2.85-$3.00 » 07:11
08/09/22
08/09
07:11
08/09/22
07:11
NOVT

Novanta

$151.89 /

-0.42 (-0.28%)

FY22 consensus $3.00.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NOVT Novanta
$151.89 /

-0.42 (-0.28%)

NOVT Novanta
$151.89 /

-0.42 (-0.28%)

06/08/22
Baird to hold a conference
06/07/22
Baird to hold a conference
05/11/22 William Blair
Novanta upgraded to Outperform after 35% pullback at William Blair
05/11/22 William Blair
Novanta upgraded to Outperform from Market Perform at William Blair
NOVT Novanta
$151.89 /

-0.42 (-0.28%)

NOVT Novanta
$151.89 /

-0.42 (-0.28%)

Hot Stocks
Axsome Therapeutics expects cash to fund operations into 2024 » 07:11
08/09/22
08/09
07:11
08/09/22
07:11
AXSM

Axsome Therapeutics

$43.33 /

-0.58 (-1.32%)

Axsome believes that its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AXSM Axsome Therapeutics
$43.33 /

-0.58 (-1.32%)

AXSM Axsome Therapeutics
$43.33 /

-0.58 (-1.32%)

07/08/22 Morgan Stanley
Axsome Therapeutics price target raised to $54 from $27 at Morgan Stanley
06/29/22 Cowen
Axsome Therapeutics price target raised to $130 from $120 at Cowen
06/29/22 Cantor Fitzgerald
Axsome Therapeutics price target raised to $64 from $47 at Cantor Fitzgerald
05/06/22 Morgan Stanley
Morgan Stanley says 'outsized pressure' on Axsome may be due to conference news
AXSM Axsome Therapeutics
$43.33 /

-0.58 (-1.32%)

AXSM Axsome Therapeutics
$43.33 /

-0.58 (-1.32%)

AXSM Axsome Therapeutics
$43.33 /

-0.58 (-1.32%)

Earnings
Achilles Therapeutics reports Q2 EPS (44c), consensus (56c) » 07:11
08/09/22
08/09
07:11
08/09/22
07:11
ACHL

Achilles Therapeutics

$3.04 /

+0.09 (+3.05%)

"We remain focused…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ACHL Achilles Therapeutics
$3.04 /

+0.09 (+3.05%)

ACHL Achilles Therapeutics
$3.04 /

+0.09 (+3.05%)

05/27/22 Piper Sandler
Achilles Therapeutics price target lowered to $10 from $17 at Piper Sandler
05/10/22 Piper Sandler
Achilles Therapeutics price target lowered to $17 from $20 at Piper Sandler
03/01/22 Piper Sandler
Achilles Therapeutics price target lowered to $20 from $23 at Piper Sandler
11/12/21 Piper Sandler
Achilles provides clinical update for ATL001 trials, says Piper Sandler
ACHL Achilles Therapeutics
$3.04 /

+0.09 (+3.05%)

Hot Stocks
FedEx to pilot ten Ford E-Transit vans across SameDay City network » 07:11
08/09/22
08/09
07:11
08/09/22
07:11
FDX

FedEx

$229.07 /

-5.8 (-2.47%)

, F

Ford

$15.78 /

+0.485 (+3.17%)

FedEx Office, a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FDX FedEx
$229.07 /

-5.8 (-2.47%)

F Ford
$15.78 /

+0.485 (+3.17%)

FDX FedEx
$229.07 /

-5.8 (-2.47%)

08/02/22 Craig-Hallum
Berkshire Grey pact with FedEx 'significant catalyst,' says Craig-Hallum
07/01/22 Berenberg
FedEx downgraded to Hold from Buy at Berenberg
06/30/22 BofA
FedEx price target raised to $287 from $276 at BofA
06/30/22 KeyBanc
FedEx price target raised to $325 from $300 at KeyBanc
F Ford
$15.78 /

+0.485 (+3.17%)

08/02/22 Citi
Citi ticks up Ford target, closes 'Upside Catalyst Watch'
08/01/22 Benchmark
Ford price target lowered to $23 from $25 at Benchmark
07/28/22 Deutsche Bank
Ford price target raised to $13 from $12 at Deutsche Bank
07/26/22 JPMorgan
Ford price target lowered to $19 from $21 at JPMorgan
FDX FedEx
$229.07 /

-5.8 (-2.47%)

F Ford
$15.78 /

+0.485 (+3.17%)

FDX FedEx
$229.07 /

-5.8 (-2.47%)

F Ford
$15.78 /

+0.485 (+3.17%)

FDX FedEx
$229.07 /

-5.8 (-2.47%)

F Ford
$15.78 /

+0.485 (+3.17%)

FDX FedEx
$229.07 /

-5.8 (-2.47%)

F Ford
$15.78 /

+0.485 (+3.17%)

Earnings
Axsome Therapeutics reports Q2 EPS ($1.06), consensus ($1.24) » 07:11
08/09/22
08/09
07:11
08/09/22
07:11
AXSM

Axsome Therapeutics

$43.33 /

-0.58 (-1.32%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AXSM Axsome Therapeutics
$43.33 /

-0.58 (-1.32%)

AXSM Axsome Therapeutics
$43.33 /

-0.58 (-1.32%)

07/08/22 Morgan Stanley
Axsome Therapeutics price target raised to $54 from $27 at Morgan Stanley
06/29/22 Cowen
Axsome Therapeutics price target raised to $130 from $120 at Cowen
06/29/22 Cantor Fitzgerald
Axsome Therapeutics price target raised to $64 from $47 at Cantor Fitzgerald
05/06/22 Morgan Stanley
Morgan Stanley says 'outsized pressure' on Axsome may be due to conference news
AXSM Axsome Therapeutics
$43.33 /

-0.58 (-1.32%)

AXSM Axsome Therapeutics
$43.33 /

-0.58 (-1.32%)

AXSM Axsome Therapeutics
$43.33 /

-0.58 (-1.32%)

Recommendations
Waste Connections price target raised to $154 from $145 at Deutsche Bank » 07:10
08/09/22
08/09
07:10
08/09/22
07:10
WCN

Waste Connections

$139.54 /

+1.16 (+0.84%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WCN Waste Connections
$139.54 /

+1.16 (+0.84%)

WCN Waste Connections
$139.54 /

+1.16 (+0.84%)

08/04/22 BMO Capital
Waste Connections price target raised to $151 from $143 at BMO Capital
06/22/22 Morgan Stanley
Waste Connections price target lowered to $138 from $150 at Morgan Stanley
06/22/22 Morgan Stanley
Waste Management price target lowered to $160 from $165 at Morgan Stanley
04/07/22 Scotiabank
Waste Connections downgraded to Sector Perform from Outperform at Scotiabank
WCN Waste Connections
$139.54 /

+1.16 (+0.84%)

WCN Waste Connections
$139.54 /

+1.16 (+0.84%)

Hot Stocks
Endeavour Silver sees FY22 production 2,100tpd-2,400tpd » 07:10
08/09/22
08/09
07:10
08/09/22
07:10
EXK

Endeavour Silver

$3.77 /

+0.08 (+2.17%)

Consolidated Silver…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EXK Endeavour Silver
$3.77 /

+0.08 (+2.17%)

EXK Endeavour Silver
$3.77 /

+0.08 (+2.17%)

05/27/22 Stifel
Endeavour Silver price target lowered to C$6.50 from C$7.50 at Stifel
05/12/22 BMO Capital
Endeavour Silver price target lowered to C$5.25 from C$6 at BMO Capital
05/12/22 TD Securities
Endeavour Silver price target lowered to C$5.50 from C$7 at TD Securities
04/12/22 BMO Capital
Endeavour Silver price target raised to C$6 from C$5.75 at BMO Capital
EXK Endeavour Silver
$3.77 /

+0.08 (+2.17%)

  • 16
    Mar
EXK Endeavour Silver
$3.77 /

+0.08 (+2.17%)

EXK Endeavour Silver
$3.77 /

+0.08 (+2.17%)

Recommendations
Republic Services price target raised to $158 from $147 at Deutsche Bank » 07:10
08/09/22
08/09
07:10
08/09/22
07:10
RSG

Republic Services

$142.87 /

+0.875 (+0.62%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RSG Republic Services
$142.87 /

+0.875 (+0.62%)

RSG Republic Services
$142.87 /

+0.875 (+0.62%)

06/22/22 Morgan Stanley
Republic Services price target lowered to $142 from $152 at Morgan Stanley
06/22/22 Morgan Stanley
Waste Management price target lowered to $160 from $165 at Morgan Stanley
06/16/22 Deutsche Bank
Deutsche Bank upgrades Republic Services to Buy as 'inflation hedge'
06/16/22 Deutsche Bank
Republic Services upgraded to Buy from Hold at Deutsche Bank
RSG Republic Services
$142.87 /

+0.875 (+0.62%)

RSG Republic Services
$142.87 /

+0.875 (+0.62%)

RSG Republic Services
$142.87 /

+0.875 (+0.62%)

Earnings
Quotient sees 2023 revenue $39M-$42M, consensus $40.87M » 07:10
08/09/22
08/09
07:10
08/09/22
07:10
QTNT

Quotient

/

+

Capital expenditures for…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
QTNT Quotient
/

+

QTNT Quotient
/

+

06/29/22 Cowen
Quotient price target lowered to $3 from $9 at Cowen
06/29/22 BTIG
Quotient price target lowered to $1.50 from $9.00 at BTIG
05/09/22 BTIG
Quotient transferred with a Buy at BTIG
12/16/21 BTIG
Quotient price target lowered to $11 from $13 at BTIG
QTNT Quotient
/

+

  • 24
    Jun
QTNT Quotient
/

+

General news
Market Update: » 07:10
08/09/22
08/09
07:10
08/09/22
07:10
$ECON

Economic Data

/

+

Market Update: Bonds are…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Earnings
Novanta sees Q3 adjusted EPS 71c-76c, consensus 77c » 07:09
08/09/22
08/09
07:09
08/09/22
07:09
NOVT

Novanta

$151.89 /

-0.42 (-0.28%)

Sees Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NOVT Novanta
$151.89 /

-0.42 (-0.28%)

NOVT Novanta
$151.89 /

-0.42 (-0.28%)

06/08/22
Baird to hold a conference
06/07/22
Baird to hold a conference
05/11/22 William Blair
Novanta upgraded to Outperform after 35% pullback at William Blair
05/11/22 William Blair
Novanta upgraded to Outperform from Market Perform at William Blair
NOVT Novanta
$151.89 /

-0.42 (-0.28%)

NOVT Novanta
$151.89 /

-0.42 (-0.28%)

Hot Stocks
Galera expects cash to fund operations for at least next twelve months » 07:09
08/09/22
08/09
07:09
08/09/22
07:09
GRTX

Galera Therapeutics

$1.23 /

+0.04 (+3.36%)

As of June 30, 2022,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GRTX Galera Therapeutics
$1.23 /

+0.04 (+3.36%)

GRTX Galera Therapeutics
$1.23 /

+0.04 (+3.36%)

05/27/22 BofA
Galera Therapeutics downgraded to Underperform from Neutral at BofA
12/20/21 Citi
Galera Therapeutics price target raised to $20 from $11 at Citi
12/15/21 H.C. Wainwright
Galera Therapeutics upgraded to Buy from Neutral at H.C. Wainwright
12/14/21 BTIG
Galera Therapeutics upgraded to Buy from Neutral at BTIG
GRTX Galera Therapeutics
$1.23 /

+0.04 (+3.36%)

Earnings
Galera Therapeutics reports Q2 EPS (54c), consensus (53c) » 07:09
08/09/22
08/09
07:09
08/09/22
07:09
GRTX

Galera Therapeutics

$1.23 /

+0.04 (+3.36%)

"During this past…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GRTX Galera Therapeutics
$1.23 /

+0.04 (+3.36%)

GRTX Galera Therapeutics
$1.23 /

+0.04 (+3.36%)

05/27/22 BofA
Galera Therapeutics downgraded to Underperform from Neutral at BofA
12/20/21 Citi
Galera Therapeutics price target raised to $20 from $11 at Citi
12/15/21 H.C. Wainwright
Galera Therapeutics upgraded to Buy from Neutral at H.C. Wainwright
12/14/21 BTIG
Galera Therapeutics upgraded to Buy from Neutral at BTIG
GRTX Galera Therapeutics
$1.23 /

+0.04 (+3.36%)

Recommendations
Quaker Houghton price target raised to $210 from $175 at Deutsche Bank » 07:09
08/09/22
08/09
07:09
08/09/22
07:09
KWR

Quaker Houghton

$186.21 /

-1.965 (-1.04%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KWR Quaker Houghton
$186.21 /

-1.965 (-1.04%)

KWR Quaker Houghton
$186.21 /

-1.965 (-1.04%)

05/16/22 Deutsche Bank
Quaker Houghton price target lowered to $175 from $225 at Deutsche Bank
03/01/22 Deutsche Bank
Quaker Houghton price target lowered to $225 from $305 at Deutsche Bank
01/18/22 Seaport Global
Quaker Houghton upgraded to Buy from Neutral at Seaport Global
01/18/22 Seaport Global
Quaker Houghton upgraded to Buy from Neutral at Seaport Global
KWR Quaker Houghton
$186.21 /

-1.965 (-1.04%)

Recommendations
Estee Lauder price target lowered to $266 from $274 at Deutsche Bank » 07:08
08/09/22
08/09
07:08
08/09/22
07:08
EL

Estee Lauder

$270.35 /

-0.31 (-0.11%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EL Estee Lauder
$270.35 /

-0.31 (-0.11%)

EL Estee Lauder
$270.35 /

-0.31 (-0.11%)

07/21/22 JPMorgan
Estee Lauder price target lowered to $265 from $270 at JPMorgan
05/31/22 Oppenheimer
Estee Lauder added back to Top Pick status at Oppenheimer
05/04/22 RBC Capital
Estee Lauder price target lowered to $322 from $361 at RBC Capital
05/04/22 Raymond James
Estee Lauder price target lowered to $320 from $345 at Raymond James
EL Estee Lauder
$270.35 /

-0.31 (-0.11%)

EL Estee Lauder
$270.35 /

-0.31 (-0.11%)

EL Estee Lauder
$270.35 /

-0.31 (-0.11%)

EL Estee Lauder
$270.35 /

-0.31 (-0.11%)

Recommendations
Upstart origination volume may have peaked, says Morgan Stanley » 07:08
08/09/22
08/09
07:08
08/09/22
07:08
UPST

Upstart

$32.30 /

+2.71 (+9.16%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UPST Upstart
$32.30 /

+2.71 (+9.16%)

UPST Upstart
$32.30 /

+2.71 (+9.16%)

06:39 Today Stephens
Upstart price target lowered to $23 from $28 at Stephens
07/22/22 Morgan Stanley
Berkshire Hills halting additions of new Upstart loans, says Morgan Stanley
07/18/22 Piper Sandler
Upstart price target lowered to $25 from $44 at Piper Sandler
07/17/22 Barclays
Upstart price target lowered to $25 from $35 at Barclays
UPST Upstart
$32.30 /

+2.71 (+9.16%)

UPST Upstart
$32.30 /

+2.71 (+9.16%)

UPST Upstart
$32.30 /

+2.71 (+9.16%)

Earnings
Quotient reports Q1 EPS (37c) vs. (27c) last year » 07:08
08/09/22
08/09
07:08
08/09/22
07:08
QTNT

Quotient

/

+

Reports Q1 revenue $8.8M…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
QTNT Quotient
/

+

QTNT Quotient
/

+

06/29/22 Cowen
Quotient price target lowered to $3 from $9 at Cowen
06/29/22 BTIG
Quotient price target lowered to $1.50 from $9.00 at BTIG
05/09/22 BTIG
Quotient transferred with a Buy at BTIG
12/16/21 BTIG
Quotient price target lowered to $11 from $13 at BTIG
QTNT Quotient
/

+

  • 24
    Jun
QTNT Quotient
/

+

Earnings
Novanta reports Q2 adjusted EPS 78c, consensus 72c » 07:08
08/09/22
08/09
07:08
08/09/22
07:08
NOVT

Novanta

$151.89 /

-0.42 (-0.28%)

Reports Q2 revenue $215M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NOVT Novanta
$151.89 /

-0.42 (-0.28%)

NOVT Novanta
$151.89 /

-0.42 (-0.28%)

06/08/22
Baird to hold a conference
06/07/22
Baird to hold a conference
05/11/22 William Blair
Novanta upgraded to Outperform after 35% pullback at William Blair
05/11/22 William Blair
Novanta upgraded to Outperform from Market Perform at William Blair
NOVT Novanta
$151.89 /

-0.42 (-0.28%)

NOVT Novanta
$151.89 /

-0.42 (-0.28%)

Earnings
Foghorn Therapeutics reports Q2 EPS (66c), consensus (59c) » 07:08
08/09/22
08/09
07:08
08/09/22
07:08
FHTX

Foghorn Therapeutics

$16.31 /

-0.285 (-1.72%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FHTX Foghorn Therapeutics
$16.31 /

-0.285 (-1.72%)

FHTX Foghorn Therapeutics
$16.31 /

-0.285 (-1.72%)

05/20/22 H.C. Wainwright
Foghorn Therapeutics price target lowered to $18 from $25 at H.C. Wainwright
03/11/22 Wedbush
Foghorn Therapeutics added to Best Ideas List at Wedbush
11/22/21 H.C. Wainwright
Foghorn Therapeutics initiated with a Buy at H.C. Wainwright
FHTX Foghorn Therapeutics
$16.31 /

-0.285 (-1.72%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.